Biophytis (EPA:ALBPS)

REGULATED PRESS RELEASE

published on 07/30/2025 at 07:00, 6 months ago

Biophytis Joins Silver Innov', an Incubator Dedicated to the Silver Economy
Biophytis relocates to Silver Innov' in Paris, embracing the silver economy ecosystem for innovation and healthcare in aging, strengthening academic and clinical research collaborations

Innovation Biophytis Healthcare Silver Innov Aging
BRIEF

published on 07/16/2025 at 07:05, 6 months 14 days ago

Biophytis Achieves Legal Victory in Court of Cassation

Biophytis Legal Victory Court Of Cassation Negma Group Convertible Bond Dispute
REGULATED PRESS RELEASE

published on 07/16/2025 at 07:00, 6 months 14 days ago

Biophytis Wins Major Legal Victory Before the French Court of Cassation
Biophytis celebrates a major legal win at the French Court of Cassation validating its position in the dispute with Negma Group, a landmark decision protecting the company's interests

Biophytis Legal Victory Court Of Cassation Negma Group Landmark Ruling
PRESS RELEASE

published on 07/16/2025 at 06:59, 6 months 14 days ago

Biophytis Wins Major Legal Victory Before the French Court of Cassation
Biophytis celebrates major legal win as French Court of Cassation rules in its favor against Negma Group, marking a turning point in the litigation and validating the company's legal position

Biophytis Litigation Legal Victory Negma Group French Court Of Cassation
BRIEF

published on 07/15/2025 at 07:05, 6 months 15 days ago

Biophytis Partners with Lynx Analytics for AI-Driven Drug Discovery

Biophytis Drug Discovery Sarcopenia AI Partnership Lynx Analytics
REGULATED PRESS RELEASE

published on 07/15/2025 at 07:00, 6 months 15 days ago

Biophytis Partners in AI with Lynx Analytics to Accelerate Drug Discovery for Sarcopenia
Biophytis partners with Lynx Analytics to accelerate drug discovery for sarcopenia through AI collaboration. The partnership aims to develop small molecule drugs for muscle preservation and regeneration

Biophytis Drug Discovery AI Sarcopenia Lynx Analytics
BRIEF

published on 07/11/2025 at 08:19, 6 months 19 days ago

Biophytis Reports 2024 Financial Results and Strategy for 2025

Drug Discovery Partnerships Biophytis Financials 2025 Strategic Plans Phase 2 And Phase 3 Trials
REGULATED PRESS RELEASE

published on 07/11/2025 at 08:14, 6 months 19 days ago

Biophytis Reports 2024 Financial Results and 2025 Outlook
Biophytis announces 2024 financial results, 2025 outlook. Initiates Phase 2 study in obesity, Phase 3 study in sarcopenia. Strengthens drug discovery platform. Resumes trading on Euronext Growth Paris

Financial Results Biophytis Drug Discovery Phase 3 Phase 2
BRIEF

published on 07/08/2025 at 07:05, 6 months 22 days ago

Biophytis Highlights Longevity Innovation at ARC 2025

Innovation Biophytis Longevity Sarcopenia ARC 2025
REGULATED PRESS RELEASE

published on 07/08/2025 at 07:00, 6 months 22 days ago

Biophytis at the Forefront of Longevity Innovation at the World Aging & Rejuvenation Conference 2025
Biophytis SA announces participation in ARC 2025 to present results of BIO101 in sarcopenia at the World Aging & Rejuvenation Conference, aiming to strengthen scientific visibility and expand in the longevity market

Sarcopenia Biophytis SA BIO101 Longevity Market ARC 2025

Published on 01/30/2026 at 14:00, 5 hours 34 minutes ago

CCL to Hold Live Webcast to Discuss Fourth Quarter and Year End 2025 Results, Thursday, February 26, 2026, at 7:30 a.m. ET
Published on 01/30/2026 at 08:35, 10 hours 59 minutes ago

Alaska Energy Metals Announces Closing Of Life Offering of Units
Published on 01/30/2026 at 08:00, 11 hours 34 minutes ago

Troubadour Resources Intercepts Target Mineralization Near Surface during Phase 1 of the Multi-Phase Drill Program at Senneville Gold-Silver-Copper Property
Published on 01/30/2026 at 02:15, 17 hours 19 minutes ago

Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 19 hours 34 minutes ago

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies

View all ACCESSWIRE

Published on 01/30/2026 at 19:13, 21 minutes ago

Total Voting Rights
Published on 01/30/2026 at 18:31, 1 hour 3 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 01/30/2026 at 18:30, 1 hour 3 minutes ago

HOL-Holdings in Company
Published on 01/30/2026 at 18:23, 1 hour 11 minutes ago

TVR-Total Voting Rights
Published on 01/30/2026 at 18:17, 1 hour 16 minutes ago

POS-Transaction in Own Shares

View all EQS

Published on 01/30/2026 at 17:45, 1 hour 49 minutes ago

Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 08:00, 11 hours 34 minutes ago

AMA: 4th Quarter & FY 2025 Revenues
Published on 01/29/2026 at 18:00, 1 day 1 hour ago

GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 1 day 1 hour ago

LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 1 day 1 hour ago

Cegedim generated LFL revenue growth of 1.1% in 2025

View all LES ECHOS COMFI WIRE

News